In This Article:
As global markets face challenges with U.S. recession concerns and trade policy uncertainties, Asia's markets have shown resilience, with Chinese stocks rising on stimulus hopes and Japanese indices gaining modestly despite global trade worries. In this environment, identifying promising small-cap stocks in Asia requires a keen eye for companies that can leverage local economic policies and sectoral growth trends to navigate broader market volatility effectively.
Top 10 Undiscovered Gems With Strong Fundamentals In Asia
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| Intelligent Wave | NA | 7.78% | 15.50% | ★★★★★★ |
| Lumax International | NA | 4.43% | 5.77% | ★★★★★★ |
| Central Forest Group | NA | 5.93% | 20.71% | ★★★★★★ |
| Otec | 8.17% | 3.43% | 1.06% | ★★★★★★ |
| Ohashi Technica | NA | 4.58% | -14.04% | ★★★★★★ |
| Shangri-La Hotel | NA | 15.26% | 23.20% | ★★★★★★ |
| Donpon Precision | 38.56% | 0.47% | 48.37% | ★★★★★★ |
| HeadwatersLtd | NA | 25.49% | 288.57% | ★★★★★★ |
| Hansae Yes24 Holdings | 80.77% | 1.28% | 9.02% | ★★★★☆☆ |
| Alltek Technology | 166.36% | 7.57% | 13.88% | ★★★★☆☆ |
We'll examine a selection from our screener results.
Philippine Seven
Simply Wall St Value Rating: ★★★★★☆
Overview: Philippine Seven Corporation operates convenience stores in the Philippines with a market capitalization of ₱82.83 billion.
Operations: Philippine Seven Corporation generates revenue primarily from its store operations, amounting to ₱88.61 billion. The company focuses on optimizing its cost structure to enhance profitability, with a gross profit margin of 31.5%.
Philippine Seven, a notable player in the retail sector, has demonstrated impressive financial resilience. Over the past year, its earnings surged by 26%, outpacing the Consumer Retailing industry's growth of 8.8%. The company's debt management is commendable with a debt to equity ratio dropping from 12.4% to just 1% over five years and interest payments well-covered at 6.3 times by EBIT. Despite recent delisting due to inactivity, SEVN's future remains promising with forecasted earnings growth of 17% annually and more cash than total debt, indicating robust financial health and potential for sustained performance.
-
Navigate through the intricacies of Philippine Seven with our comprehensive health report here.
-
Understand Philippine Seven's track record by examining our Past report.
MicroPort NeuroScientific
Simply Wall St Value Rating: ★★★★★★
Overview: MicroPort NeuroScientific Corporation focuses on the research, development, production, and sale of neuro-interventional medical devices in China and globally, with a market capitalization of HK$7.39 billion.